(Q35611136)

Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 August 2017

Tomas Berl

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14684677

retrieved

9 August 2017

publication date

1 January 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14684677

retrieved

9 August 2017

published in

Journal of the American Society of Nephrology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14684677

retrieved

9 August 2017

volume

15 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14684677

retrieved

9 August 2017

page(s)

S71-6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14684677

retrieved

9 August 2017

cites work

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/S0140-6736(03)12229-5

Identifiers

DOI

10.1097/01.ASN.0000093235.09769.9C

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14684677

retrieved

9 August 2017

PubMed publication ID

14684677

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14684677

retrieved

9 August 2017

(Q35611136)

Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)